Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%

Exclusion Criteria

• •Subjects with any condition or presentation that may, in the opinion of the investigator, may put the subject at risk, may confound study results, or may interfere with participation in the study.
• •Subjects with any known allergies to any of the ingredients listed on the test article label or surgical ink.
• •Subjects who are pregnant or breast-feeding, or who plan to become pregnant or breast feed during the course of the trial.
• •Subjects that are relatives of the investigator, or are themselves or a relative of any study staff or any Galderma employee.
• •Subjects who have participated in an investigational study within 30 days of enrollment; participated in biologic investigational studies within 90 days of enrollment, or subjects planning to participate in any other interventional clinical research study while enrolled in this trial.